Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chuikyo Recommends NHI Price Listing for 14 Products (9 APIs)
October 1, 2007
- Pharmacoeconomics Essential for Assessing Drugs: Dr Aoki
October 1, 2007
- REGULATORY NEWS IN BRIEF
October 1, 2007
- Survey：Survey Shows 90% of IBS Patients Not Aware They Have a Disease
October 1, 2007
- Combined Sales Up 13.8% for JGPMA Member Companies
October 1, 2007
- Primary Doctor System Proposed by Korosho Interferes with Patients' Free Access to Medical Services: JMA
October 1, 2007
- Domestic Drug Makers Enthusiastic about Partnering with Japanese Bioventures
October 1, 2007
- MEDICAL DEVICE NEWS IN BRIEF
October 1, 2007
- Biopharmaceuticals to Account for 45% of Sales in 2010: Wyeth
October 1, 2007
- 41% of Adults Have Undergone Upper GI Endoscopy: Olympus Awareness Survey
October 1, 2007
- Pharma Summit at Bio Japan 2007
October 1, 2007
- DSM to Expand Lineup of Materials for Devices in the Field of Orthopedic Surgery
October 1, 2007
- MTPC to Develop Flexible Computer Systems to Quickly Respond to Market Changes
October 1, 2007
- Tokyo Boeki Machinery to Launch BIOLIS mini
October 1, 2007
- ASKA Licenses New Oral Formulation Technology from LINTEC
October 1, 2007
- Olympus to Launch Capsule Endoscope System in US
October 1, 2007
- Oncodesign Hosts Japanese Pharma Industry Group
October 1, 2007
- R&D NEWS IN BRIEF
October 1, 2007
- Environment to Allow Both Work and Childcare Needed to Retain Female MRs
October 1, 2007
- Feasibility Studies for Joint Clinical Trials in Asia Increasing: CMIC
October 1, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…